$2.97 +0.01 (%) Aastrom Biosciences Inc - NASDAQ

Oct. 23, 2014 | 01:29 PM

Partner Headlines

  1. Aastrom Biosciences Announces Plans To Change Name To Vericel Corporation And Move Headquarters To Cambridge, Massachusetts

    Benzinga | Oct. 9, 2014 | 17:30PM EST
  2. Stocks Hitting 52-Week Lows

    Benzinga | Sep. 11, 2014 | 10:10AM EST
  3. Morning Market Losers

    Benzinga | Sep. 11, 2014 | 09:45AM EST
  4. Morning Market Losers

    Benzinga | Sep. 2, 2014 | 09:52AM EST
  5. Morning Market Movers

    Benzinga | Aug. 22, 2014 | 09:44AM EST
  6. Earnings Scheduled For August 13, 2014

    Benzinga | Aug. 13, 2014 | 05:53AM EST
  7. Aastrom Announces Appointment of Zac Taylor As National Sales Director

    Benzinga | Jul. 14, 2014 | 08:32AM EST
  8. Morning Market Movers

    Benzinga | Apr. 21, 2014 | 09:47AM EST
  9. Aastrom Announces Definitive Agreement to Acquire Sanofi's Cell Therapy and Regenerative Medicine Business for $6.5M Cash

    Benzinga | Apr. 21, 2014 | 08:32AM EST
  10. Morning Market Movers

    Benzinga | Apr. 9, 2014 | 09:39AM EST
  11. Morning Market Losers

    Benzinga | Mar. 24, 2014 | 09:44AM EST
  12. Stocks Hitting 52-Week Lows

    Benzinga | Oct. 11, 2013 | 10:01AM EST
  13. Aastrom Biosciences Announces One-for-Twenty Reverse Stock Split

    Benzinga | Oct. 10, 2013 | 16:15PM EST
  14. Heidi Hagen Joins Aastrom Board of Directors

    Benzinga | Aug. 26, 2013 | 16:12PM EST
  15. UPDATE: JMP Securities Lowers PT on Aastrom Biosciences Following 2Q13 EPS Loss

    Benzinga | Aug. 16, 2013 | 11:05AM EST
  16. Top Narrow Based Indexes For January 9, 2013

    Benzinga | Jan. 9, 2013 | 03:24AM EST
  17. Benzinga's Small Cap Movers for Thursday December 13, 2012

    Benzinga | Dec. 13, 2012 | 15:23PM EST
  18. Stocks Hitting 52-Week Lows

    Benzinga | Nov. 21, 2012 | 03:19AM EST
  19. Stocks Hitting 52-Week Lows

    Benzinga | Oct. 8, 2012 | 04:26AM EST
  20. Manchester United, InterMune Among Stocks hitting 52-Week Lows Monday

    FoxBusiness | Aug. 20, 2012 | 06:33AM EST
  21. Aastrom Biosciences Inc. Reports Operating Results (10-Q)

    GuruFocus | Aug. 7, 2012 | 13:33PM EST
  22. Oppenheimer Reiterates Perform Rating for Aastrom Biosciences

    Benzinga | May. 11, 2012 | 13:18PM EST
  23. Aastrom Biosciences Announces Initiation of Patient Enrollment in REVIVE Phase 3 Clinical Trial of Ixmyelocel-T

    Benzinga | Feb. 29, 2012 | 09:31AM EST
  24. FDA Warns About Unproven Stem Cell Claims

    Benzinga | Jan. 8, 2012 | 12:11PM EST
  25. Weekly CFO Sells Highlight: P, MTOR, PSSI, ASTM

    GuruFocus | Jan. 8, 2012 | 11:03AM EST
  26. Aastrom Biosciences Inc. (ASTM) CFO Scott Durbin sells 40,000 Shares

    GuruFocus | Jan. 6, 2012 | 11:39AM EST
Trading Center